2021
DOI: 10.1016/j.jconrel.2020.10.056
|View full text |Cite
|
Sign up to set email alerts
|

Fused Deposition Modeling (FDM), the new asset for the production of tailored medicines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
55
0
2

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 103 publications
(57 citation statements)
references
References 112 publications
0
55
0
2
Order By: Relevance
“…The contact causes the filament to soften into a semi-solid state that forms the sequential layers by extrusion. The heating head or a bed moves in three dimensions, which allows the layers to deposit with great precision [111]. This extrusion method is widely employed for thermo-responsive polymers allowing larger constructs than other alternatives [112].…”
Section: D Printingmentioning
confidence: 99%
“…The contact causes the filament to soften into a semi-solid state that forms the sequential layers by extrusion. The heating head or a bed moves in three dimensions, which allows the layers to deposit with great precision [111]. This extrusion method is widely employed for thermo-responsive polymers allowing larger constructs than other alternatives [112].…”
Section: D Printingmentioning
confidence: 99%
“…Different 3D printing techniques have been investigated to produce SOFs such as binder and material jetting [ 17 , 18 , 19 ], fused deposition modeling (FDM) [ 20 , 21 , 22 ], semi-solid extrusion (SSE) [ 23 , 24 ], stereolithography (SLA) [ 25 , 26 ] and selective laser sintering (SLS) [ 27 ]. Although since 2014 the majority of the articles has focused on FDM technology, describing it as the most promising [ 28 ]; SLS has gained considerable attention in the last four years (from 2017 to 2020) accumulating a total of 14 research articles [ 27 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ] and two reviews [ 42 , 43 ].…”
Section: Introductionmentioning
confidence: 99%
“…The potential and cost-effectiveness of 3D printing in the manufacturing of personalized and innovative drug products, especially when small batches are involved, were largely confirmed in the last five years [30][31][32][33][34]. Great attention is currently being paid to versatility-oriented design strategies and scale-down fabrication opportunities, which could better suit the rising needs of precision medicine [35][36][37][38]. This involves tailoring the medical treatment to the peculiar characteristics of small groups of patients or even to those of each individual, and could include type, dose, administration mode, composition and release performance of the DDS under development.…”
Section: Introductionmentioning
confidence: 99%